ABSTRACT
OBJECTIVE: A narrative overview of regional academic research collaborations to address the increasing burden and gaps in care for patients at risk of, and who suffer from, stroke in Latin America (LA). MATERIALS AND METHODS: A summary of experiences and knowledge of the local situation is presented. No systematic literature review was performed. RESULTS: The rapidly increasing burden of stroke poses immense challenges in LA, where prevention and manage-ment strategies are highly uneven and inadequate. Clinical research is increasing through various academic consortia and networks formed to overcome structural, funding and skill barriers. However, strengthening the ability to generate, analyze and interpret randomized evidence is central to further develop effective therapies and healthcare systems in LA. CONCLUSIONS: Regional networks foster the conduct of multicenter studies -particularly randomized controlled trials-, even in resource-poor regions. They also contribute to the external validity of international studies and strengthen systems of care, clinical skills, critical thinking, and international knowledge exchange.
Subject(s)
Delivery of Health Care , Stroke , Clinical Competence , Humans , Latin America , Organizations , Stroke/epidemiology , Stroke/therapyABSTRACT
Background and purpose; Chile has been one of the most affected countries by the COVID-19 pandemic, with one of the highest case rates per population. This has affected the epidemiological behaviour of various pathologies. We analyze the impact of the pandemic on the number of admissions due to stroke, its severity and mortality in Santiago, Chile. METHODS: a multicenter observational study based on the records of the 3 hospitals of the South East health service in Santiago, Chile. We recorded the number of patients admitted for ischemic stroke between 01 January 2020 and 30 June 2020. We grouped the cases into two periods, pre-pandemic and pandemic, according to the setting of the state of emergency in Chile. RESULTS: 431 patients were admitted with ischemic stroke during the study period. There was a non-significant decrease in weekly admissions (17 vs 15 patients per week). No differences were observed in the proportion of patients with medical treatment (p = 0.810), IVT (p = 0.638), EVT (p = 0.503) or IVT + EVT (p = 0.501). There was a statistically significant increase in the NIHSS on admission (7.23 vs 8.78, p = 0.009) and mortality (5.2% vs 12.4%, p = 0.012). In a multivariate analysis the NIHSS on admission was associated with the increased mortality (RR 1.11, CI 1.04-1.19, p = 0.003). CONCLUSION: We found an increase in the severity of ischemic stroke on admission and in-hospital mortality during the pandemic period. The main factor to increase in-hospital mortality was the NIHSS on admission.
Subject(s)
COVID-19/mortality , Ischemic Stroke/mortality , Aged , Aged, 80 and over , COVID-19/diagnosis , Chile/epidemiology , Disability Evaluation , Female , Hospital Mortality , Humans , Ischemic Stroke/diagnosis , Male , Middle Aged , Patient Admission , Prognosis , Risk Assessment , Risk Factors , Severity of Illness Index , Time FactorsABSTRACT
Resumen Presentamos el registro de un individuo de oso hormiguero norteño (Tamandua mexicana) con color de pelaje anormalmente blanco. Este individuo fue fotografiado con una cámara trampa en el bosque seco ecuatorial en el departamento de Lambayeque, a 560 m de altitud, en del noroeste del Perú. No pudimos diferenciar si la causa de esta aberración cromática correspondió a un caso de albinismo o de leucismo, sin embargo, destacamos este primer registro excepcional para la especie en Perú. Adicionalmente, hacemos una revisión de su presencia en el extremo sur de su distribución global.
Abstract We present the record of an individual of northern tamandua (Tamandua mexicana) with abnormal white coloration that was photographed with a camera trap in the equatorial dry forest in the department of Lambayeque, at elevation of 560 m, northwest Peru. We could not determine if this chromatic aberration was a case of leucism or albinism, but we highlight this uncommon record as the first for Peru. We also revised the information about its presence in the southern portion of its global range.
ABSTRACT
Approximately 25%-40% of ischemic strokes are considered of unknown cause (ie, cryptogenic). The available information on associated risk factors, functional outcome, and recurrence of this subtype of stroke is limited, especially for the Chilean population. We conducted a prospective cohort study of 380 patients aged ≥ 18 years admitted consecutively to a stroke unit with demonstrated ischemic stroke. The stroke subtypes were classified according to the Trial of Org 10172 in Acute Stroke Treatment criteria. The modified Rankin Scale score and Barthel Index were used to assess functional outcome. The Kaplan-Meier product-limit method and Cox proportional hazards regression analysis were used to identify predictors of recurrent stroke during the follow-up period (mean, 2.1 years). Cryptogenic stroke (CS) was diagnosed in 76 patients (20%), 55.2% of them male, with a mean age of 62 ± 17 years. CS was the third most common stroke subtype after the large-artery disease (29%) and cardioembolic (24.4%) subtypes. After adjustment for age and sex, no vascular risk factors or laboratory parameters assessed at the time of admission were found to be predictive of CS. The CS subtype had the lowest rate of stroke recurrence at the end of the follow-up period (n = 4; 2.5% per year; odds ratio, 0.32; 95% confidence interval, 0.11-0.91; P = .022), a favorable functional outcome (mean modified Rankin Scale score, 2; mean Barthel Index, 77), and no increase in mortality risk (odds ratio, 0.73; 95% confidence interval, 0.29-1.77; P = .48). Our findings demonstrate that patients with no definite etiology identified after an extensive workup are at lower risk of recurrence and more likely to have a favorable outcome. No risk factors distinguish CS from other stroke subtypes in our study population.
Subject(s)
Brain Ischemia/epidemiology , Stroke/epidemiology , Adult , Aged , Aged, 80 and over , Brain Ischemia/diagnosis , Brain Ischemia/mortality , Chi-Square Distribution , Chile/epidemiology , Diagnostic Imaging/methods , Disability Evaluation , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Prognosis , Proportional Hazards Models , Prospective Studies , Recurrence , Risk Factors , Stroke/diagnosis , Stroke/mortality , Time Factors , Young AdultABSTRACT
A rare congenital myocardial defect, known as left ventricular hypertrabeculation/non-compaction (LVHT), has been occasionally described associated with thrombus formation with a potential systemic embolic risk, but its association with ischemic strokes remains controversial. We report a case of ischemic stroke in a patient with severe LVHT and ventricular dysfunction as a possible etiologic synergistic association. In absence of other embolic sources, a severe LVTH associated with ventricular dysfunction could constitute a potential source of brain embolism, especially in patients with high suspicion of an embolic mechanism of ischemic stroke.
Subject(s)
Hypertrophy, Left Ventricular/complications , Intracranial Embolism/etiology , Stroke/etiology , Ventricular Dysfunction, Left/complications , Brain Ischemia/etiology , Humans , Hypertrophy, Left Ventricular/diagnostic imaging , Male , Middle Aged , UltrasonographyABSTRACT
Um raro defeito congênito do miocárdio, conhecido como hipertrabeculação/não-compactação do ventrículo esquerdo (HTVE/NCVE) tem sido ocasionalmente descrito em associação com a formação de trombos com um potencial risco embólico sistêmico, mas sua associação com derrames isquêmicos permanece controversa. Reportamos o caso de um derrame isquêmico em paciente com grave (HTVE/NCVE) e disfunção ventricular como uma possível associação sinérgica etiológica. Na ausência de outras fontes embólicas, uma grave HTVE/NCVE associada com disfunção ventricular poderia constituir uma fonte potencial de embolismo cerebral, especialmente em pacientes com alta suspeita de um mecanismo embólico de derrame sistêmico.
A rare congenital myocardial defect, known as left ventricular hypertrabeculation/non-compaction (LVHT), has been occasionally described associated with thrombus formation with a potential systemic embolic risk, but its association with ischemic strokes remains controversial. We report a case of ischemic stroke in a patient with severe LVHT and ventricular dysfunction as a possible etiologic synergistic association. In absence of other embolic sources, a severe LVTH associated with ventricular dysfunction could constitute a potential source of brain embolism, especially in patients with high suspicion of an embolic mechanism of ischemic stroke.
Subject(s)
Humans , Male , Middle Aged , Hypertrophy, Left Ventricular/complications , Intracranial Embolism/etiology , Stroke/etiology , Ventricular Dysfunction, Left/complications , Brain Ischemia/etiology , Hypertrophy, Left VentricularABSTRACT
Se analizan nueve cirugias de revision de endoprotesis total y parcial de caderas, efectuadas en pacientes de ambos sexos cuyas edades estaban comprendidas entre los 64 y 76 años de vida durante el periodo de tiempo comprendido entre los años 1994, 1995 y 1996. Se menciona que pese a las dificultades tecnicas que implica el tratamiento en cuestion, el resultado fue bueno en ocho pacientes y regular en el restante